G-CSF mobilized CD34+ cell transplantation as regenerative medicine for patients with critical limb ischemia. - CD34+ cell transplantation for patients with CLI.

Center for Clinical and Translational Science, Shonan Kamakura General Hospital, Tokushukai Medical Group.0 个研究点目标入组 1 人开始时间: 2019年7月16日最近更新: 2023年10月17日

适应症

试验速览

阶段: 未知
状态: 已完成
发起方
入组人数: 1

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型: Interventional

入排标准

年龄范围: 20years-old 至 80years-old（—）
性别: All

入选标准

未提供

排除标准

•1) Rutherford category of 6 2) Buerger's disease 3) Within 4 weeks after revascularization therapy (bypass surgery or endovascular therapy) or low-density lipoprotein apheresis 4) Severely decreased cardiac function (under 25% of left ventricular ejection fraction on cardiac ultrasonography) 5) Allergic reaction or adverse reaction to G-CSF, the other reagents, or apheresis 6) Malignancy or history of malignancy within past 5 years 7) Advanced diabetic retinopathy 8) Within 12 weeks after myocardial infarction, unstable angina pectoris, or stroke 9) Hematologic disease (leukemia, myeloproliferative disorders, myelodysplastic syndromes, or sickle cell disease) 10) Autoimmune disorders 11) Liver cirrhosis 12) Interstitial pneumonitis or history 13) At least one laboratory abnormality (white blood cell count, under 3,000 /micro L or greater than 15,000/micro L; hemoglobin concentration, under 8 g/dL; platelet count, under 100,000/micro L; aspartate aminotransferase or alanine aminotransferase, equal or greater than 100 IU/L; and serum albumin, under 2 g/dL) 14) Splenomegaly on computed tomography 15) Pregnancy

研究者

发起方

Center for Clinical and Translational Science, Shonan Kamakura General Hospital, Tokushukai Medical Group.

相似试验

已完成

不适用

G-CSF mobilized CD34+ cell transplantation as regenerative medicine for patients with spinal cord injuries.Spinal cord injury

JPRN-UMIN000037388Center for Clinical and Translational Science, Shonan Kamakura General Hospital, Tokushukai Medical Group.6

招募中

1 期

CD34+ cell transplantation for patients with acute renal failure.

JPRN-jRCTb030190231OHTAKE Takayasu9

招募中

2 期

CD34+ cell transplantation for patients with spinal cord injuries.Spinal cord injury

JPRN-jRCTb030190220WATANABE Tsuyoshi6

招募中

2 期

CD34+ cell transplantation for patients with CLI.

JPRN-jRCTb030190142OHTAKE Takayasu20

已完成

1 期

G-CSF mobilized CD34+ cell transplantation for hemodialysis patients with critical limb ischemia.peripheral arterial disease (critical limb ischemia)

JPRN-UMIN000015266Shonan Kamakura General Hospital10